Whitehawk Therapeutics (WHWK) Receivables - Net (2022 - 2024)
Whitehawk Therapeutics (WHWK) has disclosed Receivables - Net for 3 consecutive years, with $5.9 million as the latest value for Q4 2024.
- Quarterly Receivables - Net rose 7.56% to $5.9 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $5.9 million through Dec 2024, up 7.56% year-over-year, with the annual reading at $5.9 million for FY2024, 7.56% up from the prior year.
- Receivables - Net for Q4 2024 was $5.9 million at Whitehawk Therapeutics, down from $6.5 million in the prior quarter.
- The five-year high for Receivables - Net was $6.5 million in Q3 2024, with the low at $1.9 million in Q4 2022.
- Average Receivables - Net over 3 years is $4.4 million, with a median of $5.2 million recorded in 2023.
- The sharpest move saw Receivables - Net skyrocketed 194.74% in 2023, then dropped 11.36% in 2024.
- Over 3 years, Receivables - Net stood at $1.9 million in 2022, then surged by 194.74% to $5.5 million in 2023, then rose by 7.56% to $5.9 million in 2024.
- According to Business Quant data, Receivables - Net over the past three periods came in at $5.9 million, $6.5 million, and $5.9 million for Q4 2024, Q3 2024, and Q2 2024 respectively.